LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW 200,000
-1,500 (-0.74%)
Apr 24, 2026, 3:30 PM KST
LigaChem Biosciences Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -74,278 | 7,800 | -73,704 | -45,092 | -23,391 |
Depreciation & Amortization | 6,609 | 5,009 | 4,672 | 4,118 | 3,049 |
Loss (Gain) From Sale of Assets | -0.35 | -8.14 | -37.83 | -1.13 | 177.8 |
Asset Writedown & Restructuring Costs | 45 | -35 | 260.2 | 301.66 | - |
Loss (Gain) From Sale of Investments | 4,397 | -4,580 | 6,853 | 2,088 | 422.81 |
Loss (Gain) on Equity Investments | -1,280 | -840.1 | -838.1 | -52.28 | -1,030 |
Stock-Based Compensation | 3,908 | 13,544 | 4,478 | 3,104 | 1,380 |
Provision & Write-off of Bad Debts | -850.54 | -3,389 | 5,021 | 9,810 | -121.97 |
Other Operating Activities | -26,994 | -17,762 | -6,517 | 1,207 | 2,933 |
Change in Accounts Receivable | 12,827 | 4,913 | -7,072 | 9,876 | -1,779 |
Change in Inventory | 102.42 | -15.63 | 1.99 | 71.73 | 14.9 |
Change in Accounts Payable | -2,025 | 414.28 | -163.21 | 439.25 | 290.72 |
Change in Other Net Operating Assets | -46,994 | 73,426 | 4,809 | 6,996 | -23,996 |
Operating Cash Flow | -124,533 | 78,476 | -62,236 | -7,136 | -42,049 |
Capital Expenditures | -3,050 | -2,628 | -1,319 | -4,164 | -18,309 |
Sale of Property, Plant & Equipment | 0.29 | - | 38.99 | - | 0.14 |
Cash Acquisitions | 9,148 | - | - | - | - |
Sale (Purchase) of Intangibles | -2,991 | -2,930 | -882.68 | -607.82 | -134.95 |
Investment in Securities | 91,034 | -451,816 | 11,530 | -11,397 | -25,153 |
Other Investing Activities | -0 | -0 | - | -0 | -347.47 |
Investing Cash Flow | 94,141 | -457,374 | 9,367 | -16,169 | -43,944 |
Short-Term Debt Issued | - | - | 9,147 | 2,700 | - |
Long-Term Debt Issued | - | - | - | - | 8,235 |
Total Debt Issued | - | - | 9,147 | 2,700 | 8,235 |
Short-Term Debt Repaid | - | -11,847 | - | - | - |
Long-Term Debt Repaid | -871.47 | -433.27 | -9,380 | -2,888 | -206.91 |
Total Debt Repaid | -871.47 | -12,280 | -9,380 | -2,888 | -206.91 |
Net Debt Issued (Repaid) | -871.47 | -12,280 | -233.07 | -188.31 | 8,028 |
Issuance of Common Stock | 7,239 | 475,677 | 3,207 | 3,390 | 3,290 |
Repurchase of Common Stock | -6,996 | -19,956 | -4,879 | - | - |
Other Financing Activities | - | -61.6 | -4.21 | -2.64 | -26.3 |
Financing Cash Flow | -628.77 | 443,379 | -1,909 | 3,199 | 171,292 |
Foreign Exchange Rate Adjustments | 758.24 | 1,377 | -133.4 | -1,869 | -7.9 |
Net Cash Flow | -30,262 | 65,858 | -54,911 | -21,975 | 85,291 |
Free Cash Flow | -127,582 | 75,849 | -63,555 | -11,300 | -60,358 |
Free Cash Flow Margin | -90.13% | 60.25% | -186.13% | -33.82% | -187.70% |
Free Cash Flow Per Share | -3506.92 | 2182.46 | -2237.54 | -403.33 | -2501.88 |
Cash Interest Paid | 468.12 | 547.24 | 498.69 | 287.84 | 51.86 |
Cash Income Tax Paid | 8,519 | 5,944 | 1,091 | 385.68 | 82.06 |
Levered Free Cash Flow | -112,050 | 61,133 | -51,371 | -2,928 | - |
Unlevered Free Cash Flow | -111,498 | 61,448 | -51,041 | -2,749 | - |
Change in Working Capital | -36,089 | 78,738 | -2,424 | 17,381 | -25,469 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.